HealthCare Global EnterprisesNSE:HCG +5.39%81 Pretax Margin % is 0.19% as of Mar. 2026, which is 93% below its 10-year median of 2.63. GuruFocus rates NSE:HCG with a GF Score™ of 81/100 and a GF Value™ of ₹577.23 (Fairly Valued). The stock has 2 warning signs investors should review. Among 666 Healthcare Providers & Services companies, HealthCare Global Enterprises ranks worse than 60.96% on this metric.
The historical rank and industry rank for HealthCare Global Enterprises's Pretax Margin % or its related term are showing as below:
NSE:HCG'
s Pretax Margin % Range Over the Past 10 Years
Min: -22.77 Med: 2.63 Max: 6.35
Current: 1.06
NSE:HCG's Pretax Margin % is ranked worse than 60.96% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 4
vs NSE:HCG: 1.06
HealthCare Global Enterprises (NSE:HCG) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
HealthCare Global Enterprises Pretax Margin % Related Terms
HealthCare Global Enterprises Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthCare Global Enterprises Pretax Margin % Chart
NSE:HCG vs HCA, THC, DVA: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, HealthCare Global Enterprises's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthCare Global Enterprises Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where HealthCare Global Enterprises's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthCare Global Enterprises (NSE:HCG) has a Pretax Margin % of 0.19% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on HealthCare Global Enterprises and its competitors. This is 93% below median its historical median of 2.63. According to the industry distribution chart, HealthCare Global Enterprises ranks #406 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 61%.
Is HealthCare Global Enterprises' Pretax Margin % too high?
HealthCare Global Enterprises' current Pretax Margin % of 0.19% is 93% below median its 10-year median of 2.63. The Healthcare Providers & Services industry median Pretax Margin % is 4.00. HealthCare Global Enterprises' value of 0.19% is 95.3% below this industry median. Based on the distribution chart, HealthCare Global Enterprises ranks #406 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, HealthCare Global Enterprises has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' Pretax Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, HealthCare Global Enterprises ranks #406 out of 666 companies for Pretax Margin %. This places HealthCare Global Enterprises in the lower half of its industry. The industry median Pretax Margin % is 4.00. HealthCare Global Enterprises' value of 0.19% is 95.3% below this benchmark. While the company's 10-year median is 2.63 vs. the industry median of 4.00, HealthCare Global Enterprises has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.00, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthCare Global Enterprises's current Pretax Margin % of 0.19% is 95.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on HealthCare Global Enterprises and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthCare Global Enterprises's current Pretax Margin % is 0.19%, which is 93% below median its own 10-year median of 2.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Fairly Valued. The stock's GF Value™ is ₹577.23, compared to a current price of ₹627.10 — trading 8.6% above its estimated fair value. The current Pretax Margin % is 0.19%, which is 93% below median its 10-year median of 2.63 and 95.3% below the Healthcare Providers & Services industry median of 4.00. HealthCare Global Enterprises' overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current Pretax Margin % is 0.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?
Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued.
The current stock price of ₹627.10 is trading 8.6% above its estimated GF Value™ of ₹577.23.
GuruFocus considers HealthCare Global Enterprises to be Fairly Valued.
Key valuation signals for NSE:HCG:
Pretax Margin %: 0.19% (93% below median its 10-year median of 2.63)
GF Value™: ₹577.23 vs. price of ₹627.10 (8.6% above fair value)
Industry Position: 95.3% below the Healthcare Providers & Services median (#406 of 666)
No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthCare Global Enterprises Business Description
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
81GF Score
Get the complete analysis for NSE:HCG
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:HCG has been successfully added to your 
